C-B-D Becomes F.D.A. Approved AKA Mainstream?
“If the agency (F.D.A.) follows the recommendation, as is expected, the drug would be the first cannabis-derived prescription medicine available in the United States…” The article linked
Continue readingLisa’s Story-Leukemia Diagnosis of “Not Necessarily”
Does this mean I’m going to die?” Lisa asked innocently to Dr. Nantel, the hematologist at the Vancouver General Hospital. He had just diagnosed her with leukemia. “Not necessarily” was his reply Does
Continue readingIntraarterial Chemotherapy for Retinoblastoma-Pros and Cons
This article reviews the potential benefits and risks related to intra-arterial chemotherapy for retinoblastoma. While the treatment minimizes systemic toxicity as the chemotherapy is administered directly
Continue readingCardiovascular Events in Multiple Myeloma Therapy
“An analysis of past studies shows 18 percent of multiple myeloma patients receiving carfilzomib experience cardiovascular adverse events (CVAE) such as hypertension, heart failure, heart attacks,
Continue readingKyprolis vs. Bortizomib heart damage in Multiple Myeloma
“In patients receiving therapy for relapsed multiple myeloma, heart failure, angina, and other cardiovascular adverse events occurred more frequently with carfilzomib compared with bortezomib” If
Continue readingSlow/Stop SMM’s March Toward Full-Blown Multiple Myeloma
“Hyperdiploid-myeloma is associated with male sex, kappa immunoglobulin subtype, symptomatic bone disease and better survival compared to nonhyperdiploid-MM Hi David-I contacted you a couple months
Continue reading5 Of The Highest Paying Medical Positions In 2018
“All these medical positions require a lot of study and training. However, the money can make it all worth it. Remember, if you want to earn six figures, then you going to have to put in a lot of
Continue readingAnna Warner’s Thyroid Cancer Survivor Story
“Your thyroid gland absorbs nearly all of the iodine in your body. When radioactive iodine (RAI), also known as I-131, is taken into the body in liquid or capsule form, it concentrates in thyroid
Continue readingNathan Mumford-Minority Cancer profile in courage
Originally from Cleveland Heights, Ohio, Minority Cancer Profile In Courage, Nathan Mumford founded the Karen E. Mumford Cancer Foundation in 2007. Editor’s Note: Though Nathan Mumford is the minority
Continue readingCurcumin and Doxorubicin Combo in Relapsed/Refractory Multiple Myeloma
Conclusion: PAd is an active salvage therapy with manageable toxicity in patients with relapsed/refractory multiple myeloma. The good news is that there is a long and growing list of conventional, FDA
Continue reading